Literature DB >> 4587521

Immunogenicity of living and heat-killed Salmonella pullorum vaccines.

F M Collins.   

Abstract

Specific pathogen-free CD-1 and C57Bl mice were infected in a hind footpad with 5 x 10(4) viable Salmonella enteritidis cells or 10(7) viable S. pullorum cells. The resulting bacterial growth within the footpad, the draining lymph nodes, and the liver and spleen was followed for 14 days. Mice vaccinated with live S. enteritidis rapidly developed an effective antibacterial resistance to both intravenous and intragastric challenge with S. enteritidis SM(R). The viable inoculum of S. pullorum was rapidly eliminated from the normal mouse tissues and failed to induce a detectable anti-Salmonella resistance to parenteral or oral challenge with S. enteritidis. Heat-killed saline suspensions (200 mug, dry wt) of S. enteritidis or S. pullorum were unable to induce an effective antimicrobial resistance against a subsequent virulent Salmonella challenge. However, when the organisms were suspended in Freund complete adjuvant, both vaccines induced an antibacterial resistance to intravenous and intragastric challenge. Reduction of the antigenic dose from 200 to 40 mug did not greatly affect the protective value of the two killed vaccines against an intravenous challenge, but the level of protection observed with two 40-mug doses of S. pullorum was considerably reduced when the animals were infected intragastrically, suggesting that some quantitative differences existed between the sensitizing antigenic contents of the two test organisms.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4587521      PMCID: PMC422753          DOI: 10.1128/iai.7.5.735-742.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Delayed hypersensitivity and arthus reactivity in relation to host resistance in salmonella-infected mice.

Authors:  F M Collins; G B Mackaness
Journal:  J Immunol       Date:  1968-11       Impact factor: 5.422

Review 2.  Resistance to intracellular infection.

Authors:  G B Mackaness
Journal:  J Infect Dis       Date:  1971-04       Impact factor: 5.226

3.  Two types of immunity in experimental typhoid; "cellular immunity" and "humoral immunity".

Authors:  D Ushiba
Journal:  Keio J Med       Date:  1965-06

4.  The relationship of delayed hypersensitivity to acquired antituberculous immunity. II. Effect of adjuvant on the allergenicity and immunogenicity of heat-killed tubercle bacilli.

Authors:  F M Collins; G B Mackaness
Journal:  Cell Immunol       Date:  1970-09       Impact factor: 4.868

5.  Mechanisms in antimicrobial immunity.

Authors:  F M Collins
Journal:  J Reticuloendothel Soc       Date:  1971-07

6.  Studies on cytophilic antibodies. 1. The production by mice of macrophage cytophilic antibodies to sheep erythrocytes: relationship to the production of other antibodies and the development of delayed-type hypersensitivity.

Authors:  D S Nelson; P Mildenhall
Journal:  Aust J Exp Biol Med Sci       Date:  1967-04

7.  Immunity in Experimental Salmonellosis I. Protection Induced by Rough Mutants of Salmonella typhimurium.

Authors:  R Germanier
Journal:  Infect Immun       Date:  1970-09       Impact factor: 3.441

8.  Detection of delayed hypersensitivity in mice injected with ribonucleic acid-protein fractions of Salmonella typhimurium.

Authors:  R A Smith; N J Bigley
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

9.  Comparative immunogenicity of heat-killed and living oral Salmonella vaccines.

Authors:  F M Collins; P B Carter
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

10.  Host-parasite relations in mouse typhoid.

Authors:  G B Mackaness; R V Blanden; F M Collins
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge.

Authors:  Raphael Simon; Sharon M Tennant; James E Galen; Myron M Levine
Journal:  Vaccine       Date:  2011-05-25       Impact factor: 3.641

2.  Analysis of immunity to infection with Salmonella typhimurium in outbred mice. II. Isolation and immunogenicity of the protective non-O antigenic component from ribosomal vaccine.

Authors:  E Kita; M Emoto; N Katsui; K Nishi; K Yasui; K Yasui; S Kashiba
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

3.  Cellular and humoral aspects of host resistance in murine salmonellosis.

Authors:  N M Marecki; H S Hsu; D R Mayo
Journal:  Br J Exp Pathol       Date:  1975-06

4.  Murine model for study of cell-mediated immunity: protection against death from fully virulent Francisella tularensis infection.

Authors:  H T Eigelsbach; D H Hunter; W A Janssen; H G Dangerfield; S G Rabinowitz
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

5.  Growth of Pasteurella multocida in vaccinated and normal mice.

Authors:  F M Collins
Journal:  Infect Immun       Date:  1973-12       Impact factor: 3.441

6.  Cell-mediated immune response to Salmonella typhimurium infection in mice: development of nonspecific bactericidal activity against Listeria monocytogenes.

Authors:  R M Zinkernagel
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

7.  Comparative efficacy and toxicity of a ribosomal vaccine, acetone-killed cells, lipopolysaccharide, and a live cell vaccine prepared from Salmonella typhhimurium.

Authors:  C R Angerman; T K Eisenstein
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

8.  Immunological study of typhoid: immunoglobulins, C3, antibodies, and leukocyte migration inhibition in patients with typhoid fever and TAB-vaccinated individuals.

Authors:  R Kumar; A N Malaviya; R G Murthy; M Venkataraman; L N Mohapatra
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

9.  Growth of typhoid and paratyphoid bacilli in intravenously infected mice.

Authors:  P B Carter; F M Collins
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.